Albany Molecular Research (AMRI)

Add to Watchlists Create an Alert
11.05 +0.08  +0.73%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Albany Molecular Research Liabilities:

56.42M for March 31, 2013
View Full Chart

Albany Molecular Research Liabilities Chart

    Albany Molecular Research Historical Liabilities Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 56.42M
    Dec. 31, 2012 56.72M
    Sept. 30, 2012 59.91M
    June 30, 2012 62.38M
    March 31, 2012 58.02M
    Dec. 31, 2011 56.63M
    Sept. 30, 2011 60.33M
    June 30, 2011 65.05M
    March 31, 2011 74.35M
    Dec. 31, 2010 81.36M
    Sept. 30, 2010 75.57M
    June 30, 2010 70.30M
    March 31, 2010 60.12M
    Dec. 31, 2009 59.08M
    Sept. 30, 2009 66.79M
    June 30, 2009 68.06M
    March 31, 2009 73.48M
    Dec. 31, 2008 64.00M
    Sept. 30, 2008 58.38M
    June 30, 2008 58.47M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Total Liabilities

    Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

    Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

    Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

    Simply, liabilities are the part of a company's assets that it has yet to repay back.
    Learn More

    Get data for

    AMRI Liabilities Benchmarks

    Companies
    Cambrex Corporation 238.79M
    Achillion Pharmaceuticals 10.84M
    Anacor Pharmaceuticals 46.26M

    AMRI Liabilities Rankings

    Overall 77th percentile
    1783 of 8006
    Sector 44th percentile
    380 of 686 in Healthcare
    Industry 35th percentile
    159 of 248 in Biotechnology

    AMRI Liabilities Range, Past 5 Years

    Minimum 56.42M Mar 2013
    Maximum 81.36M Dec 2010
    Average 64.27M